Literature DB >> 11254878

HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells.

G Davies1, W G Jiang, M D Mason.   

Abstract

The effect of HGF/SF on the association between the E-cadherin/catenin complex and the tyrosine kinase receptor c-Met, was examined in prostate cancer cells LNCap FGC. Stimulation by HGF/SF showed E-cadherin and beta-catenin to be co-precipitated and located at areas of cell-cell contact with the HGF/SF receptor c-Met, as detected by immunoprecipitation and immunofluorescence respectively. Furthermore, continued exposure to this motogen increased the level of co-precipitations between the E-cadherin/catenin complex with c-Met, and also increased tyrosine phosphorylation of c-Met. In contrast, continued stimulation by HGF/SF decreased the level of co-localised peripheral staining and increased the level of cytoplasmic staining. In conclusion, the association between the E-cadherin/catenin complex with the HGF/SF receptor c-Met, may influence or regulate intercellular adhesion in prostate cancer following stimulation by HGF/SF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254878     DOI: 10.3892/ijmm.7.4.385

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

Review 1.  Intercellular junction assembly, dynamics, and homeostasis.

Authors:  Kathleen J Green; Spiro Getsios; Sergey Troyanovsky; L M Godsel
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

2.  Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo.

Authors:  Claudia D Andl; Brenton B Fargnoli; Takaomi Okawa; Mark Bowser; Munenori Takaoka; Hiroshi Nakagawa; Andres Klein-Szanto; Xianxin Hua; Meenhard Herlyn; Anil K Rustgi
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.

Authors:  Yutong Zhao; Jing Zhao; Rachel K Mialki; Jianxin Wei; Ernst W Spannhake; Ravi Salgia; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

4.  Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.

Authors:  Lan Zhou; Naili An; Rex C Haydon; Qixin Zhou; Hongwei Cheng; Ying Peng; Wei Jiang; Hue H Luu; Pantila Vanichakarn; Jan Paul Szatkowski; Jae Yoon Park; Benjamin Breyer; Tong-Chuan He
Journal:  Cancer Lett       Date:  2003-04-25       Impact factor: 8.679

Review 5.  Prostate tumor cell plasticity: a consequence of the microenvironment.

Authors:  Clayton Yates
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

6.  Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.

Authors:  Yutong Zhao; Donghong He; Randi Stern; Peter V Usatyuk; Ernst Wm Spannhake; Ravi Salgia; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2007-07-13       Impact factor: 4.315

Review 7.  Targeting tyrosine kinases and autophagy in prostate cancer.

Authors:  Hsing-Jien Kung
Journal:  Horm Cancer       Date:  2010-12-02       Impact factor: 3.869

8.  Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.

Authors:  Joanne Soong; Yulin Chen; Elina M Shustef; Glynis A Scott
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

9.  Regulation of adherens junction dynamics by phosphorylation switches.

Authors:  Cristina Bertocchi; Megha Vaman Rao; Ronen Zaidel-Bar
Journal:  J Signal Transduct       Date:  2012-07-12

10.  Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies.

Authors:  W G Jiang
Journal:  Curr Oncol       Date:  2007-04       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.